The Drug Administration of Vietnam under the Ministry of Health September 7 fined the US-invested Robinson Pharma, Inc for providing substandard to consumers.

The administration has issued a fine of VND80 million (US$3,778) the US pharmaceutical company and revoked the company’s operation license. The US-invested company will not be allowed to operate in six months.

The pharmaceutical company was requested to re-export all substandard medicines or destroy them as per the country’s regulation.

Source: SGGP